H1‐antihistamine‐refractory chronic spontaneous urticaria: it's worse than we thought – first results of the multicenter real‐life AWARE study
Clinical & Experimental Allergy2017Vol. 47(5), pp. 684–692
Citations Over TimeTop 10% of 2017 papers
Marcus Maurer, Petra Staubach, Ulrike Raap, Grit Richter‐Huhn, Andrea Bauer, Franziska Ruëff, Thilo Jakob, Amir S. Yazdi, Vera Mahler, Nicola Wagner, Undine Lippert, Uwe Hillen, Anke Schwinn, M. Pawlak, N. Behnke, Kamel Chaouche, Nadine Chapman‐Rothe
Abstract
This study reveals that German H1-antihistamine-refractory CSU patients have high rates of uncontrolled disease, angioedema, and comorbid CIndU, are undertreated, have impaired QoL, and rely heavily on healthcare resources.
Related Papers
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)